DBV Technologies S.A.

Informe acción ENXTPA:DBV

Capitalización de mercado: €52.2m

DBV Technologies Dirección

Dirección controles de criterios 3/4

El CEO de DBV Technologies es Daniel Tassé , nombrado en Nov 2018, tiene una permanencia de 5.67 años. compensación anual total es $2.40M, compuesta por 25% salario y 75% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.018% de las acciones de la empresa, por valor de €9.25K. La antigüedad media del equipo directivo y de la junta directiva es de 5.2 años y 5.7 años, respectivamente.

Información clave

Daniel Tassé

Chief Executive Officer (CEO)

US$2.4m

Compensación total

Porcentaje del salario del CEO25.0%
Permanencia del CEO6yrs
Participación del CEO0.02%
Permanencia media de la dirección5.2yrs
Promedio de permanencia en la Junta Directiva5.7yrs

Actualizaciones recientes de la dirección

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

Recent updates

DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Oct 24
DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

Aug 04
Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

Jun 14
Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

May 09
DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 14
Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 10
DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Dec 01
Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Jun 23
Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely

Mar 09
We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation

Oct 04
Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation

DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate

Aug 06
DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate

Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely

Mar 14
Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Daniel Tassé en comparación con los beneficios de DBV Technologies?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

-US$102m

Jun 30 2024n/an/a

-US$88m

Mar 31 2024n/an/a

-US$80m

Dec 31 2023US$2mUS$600k

-US$73m

Sep 30 2023n/an/a

-US$101m

Jun 30 2023n/an/a

-US$101m

Mar 31 2023n/an/a

-US$100m

Dec 31 2022US$3mUS$600k

-US$96m

Sep 30 2022n/an/a

-US$71m

Jun 30 2022n/an/a

-US$77m

Mar 31 2022n/an/a

-US$85m

Dec 31 2021US$2mUS$600k

-US$98m

Sep 30 2021n/an/a

-US$124m

Jun 30 2021n/an/a

-US$131m

Mar 31 2021n/an/a

-US$148m

Dec 31 2020US$2mUS$600k

-US$160m

Sep 30 2020n/an/a

-US$161m

Jun 30 2020n/an/a

-US$171m

Mar 31 2020n/an/a

-US$169m

Dec 31 2019US$3mUS$600k

-US$172m

Sep 30 2019n/an/a

-US$176m

Jun 30 2019n/an/a

-US$198m

Mar 31 2019n/an/a

-US$191m

Dec 31 2018US$5mUS$55k

-US$190m

Compensación vs. Mercado: La compensación total de Daniel($USD2.40M) está por encima de la media de empresas de tamaño similar en el mercado French ($USD309.80K).

Compensación vs. Ingresos: La compensación de Daniel ha sido consistente con los resultados de la empresa en el último año.


CEO

Daniel Tassé (64 yo)

6yrs

Permanencia

US$2,404,486

Compensación

Mr. Daniel Tasse had been an Independent Non-Executive Director of Indivior PLC since August 2014 until May 6, 2021 and Senior Independent Director since September 30, 2016 until May 6, 2021. Mr. Tasse ser...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Daniel Tassé
CEO & Director6yrsUS$2.40m0.018%
€ 9.2k
Virginie Simone Jeanine Boucinha
CFO & Principal Accounting Officerless than a yearUS$509.31ksin datos
Pharis Mohideen
Chief Medical Officer5.3yrsUS$1.28m0.024%
€ 12.6k
Kevin Malobisky
Chief Operations Officerless than a yearsin datossin datos
Katie Matthews
Investor Relations Officerno datasin datossin datos
Michele Robertson
Chief Legal Officer3.8yrssin datossin datos
Caroline Daniere
Chief Human Resources Officer & Chief of Staff5.2yrssin datossin datos
Wence Agbotounou
Chief Clinical Trial Officer & Senior VP8.5yrssin datossin datos
Edward Jordan
Senior Vice President of Commercial Operations North America8.8yrssin datossin datos
Alan Kerr
Senior VP & Head of Global Regulatory Affairs5.8yrssin datossin datos
Pascal Wotling
Chief External Manufacturing & Supply Chain Officerless than a yearsin datossin datos
Robert Pietrusko
Chief Regulatory Officerless than a yearsin datossin datos

5.2yrs

Permanencia media

57.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de DBV es experimentado (5.2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Daniel Tassé
CEO & Director5.7yrsUS$2.40m0.018%
€ 9.2k
Timothy Morris
Independent Director3.7yrsUS$113.54k0.012%
€ 6.5k
Michel de Rosen
Independent Chairman of the Board6.5yrsUS$10.81k0.024%
€ 12.7k
Michael Goller
Director9.1yrsUS$113.54k0%
€ 0
Daniel Soland
Independent Director9.7yrsUS$113.54k0.026%
€ 13.5k
Mailys Ferrere
Director8.4yrssin datossin datos
Hugh Sampson
Scientific Adviser to the CEO & Chairman of Scientific Advisory Board3.9yrssin datossin datos
Paul-Henri Lambert
Member of the Scientific Advisory Boardno datasin datossin datos
Emma Guttman-Yassky
Member of Scientific Advisory Board5.5yrssin datossin datos
Julie O'Neill
Director7.4yrsUS$113.54k0%
€ 0
Jean-François Nicolas
Member of Scientific Advisory Board5.5yrssin datossin datos
Jim Krueger
Member of Scientific Advisory Board5.5yrssin datossin datos

5.7yrs

Permanencia media

64yo

Promedio de edad

Junta con experiencia: La junta directiva de DBV se considera experimentada (5.7 años de antigüedad promedio).